The options for treatment of sarcoidosis have expanded. In this article, we outline a stepwise
approach to treatment. Recommendations for treatment are based on available evidence …

Treatment of sarcoidosis is controversial. The clinical expression and natural history of
sarcoidosis is variable, and spontaneous remissions occur in up to 60% of patients. The …

Sarcoidosis is a systemic inflammatory disorder of unknown etiology. Although any organ
may be involved, the lungs are most frequently affected. The clinical course of the disease is …

The treatment of sarcoidosis is not standardized. Because sarcoidosis may never cause
significant symptoms or organ dysfunction, treatment is not mandatory. When treatment is …

Sarcoidosis is a systemic granulomatous inflammatory disease of unknown etiology. It
affects the lungs in over 90% of patients yet extra-pulmonary and multi-organ involvement is …

Most cases of sarcoidosis are mild and self-limited, with a spontaneous cure. However, in
some patients, this disease may also be life-threatening, particularly when severe …

Sarcoidosis is a systemic, granulomatous disease that can affect multiple organs and has a
variable clinical course. Corticosteroids (eg prednisone) remain the mainstay of therapy in …

Corticosteroids remain the first-line therapy for sarcoidosis as many patients never require
treatment or only necessitate a short treatment duration. Second-line and third-line therapies …

Introduction: Care of patients with sarcoidosis requires familiarity with its natural history as
well as of various immunosuppressants employed in its treatment. We would like to share …

Sarcoidosis is a systemic disease of unknown etiology characterized by the presence of
noncaseating granulomas that can occur in any organ, most commonly the lungs. Early and …